Furthermore, we observed TI17 could specifically bound endogenous Trip13 derived from MM cells and the proliferative inhibitions of TI17 was increased in Trip13‐overexpressed MM cells. This evidence concerns the gene TRIP13 and Miyoshi myopathy.